A Descriptive Study to Analyze Chemotherapy-Induced Hair Loss and Its Psychosocial Impact in Adults: Our Experience from a Tertiary Care Hospital

Overview

Journal Indian Dermatol Online J

Specialty Dermatology

Date 2019 Jul 24

PMID 31334063

Citations 8

Authors

Neerja Saraswat

Ajay Chopra

Aradhana Sood

Parul Kamboj

Sushil Kumar

Affiliations

Soon will be listed here.

Abstract

Background: Hair loss is one of the most commonly reported and psychologically distressing adverse effects of chemotherapeutic agents. Studies on its impact on psychosocial aspect of cancer patients are lacking at present.

Objective: To study the chemotherapeutic agents causing hair loss and its psychosocial implications in adults.

Materials And Methods: Observational study was done for a period of 1 year, wherein all cancer patients, more than 18 years of age who developed hair loss while on chemotherapy were assessed for type of malignancy, details of chemotherapy protocol, their knowledge about chemotherapeutic agents induced hair loss, and its impact on their social life and patterns of adjustment to deal with it. A prevalidated closed-ended questionnaire was used as a data collection tool.

Results: Out of 179 patients, 96 (53.6%) were males as against 80 (44.6%) females, and 49 (27.3%) patients were between 18 and 30 years of age. Carcinoma lung was the most common malignancy seen in 46 (25.6%) patients followed by rectosigmoid carcinoma in 41 (22.9%) patients. Combination of cyclophosphamide and doxorubicin was the most common combination resulting in hair loss in 49 (27.3%) cancer patients. A total of 101 (56.4%) patients felt that hair loss was the worst side effect of chemotherapy, while 29 (16.2%) had to continue because it was life-saving. A total of 129 (72%) patients said hair loss is affecting their social life; 37 (20.6%) patients were using hair accessories while 69 (38.5%) did not even attempt to hide hair loss as they were too occupied with fear of disease.

Conclusion: Chemotherapy-induced hair loss is a common adverse effect in cancer patients undergoing treatment. A thorough counseling about it and methods to deal with it should be a part of management of the patients.

Citing Articles

Katayama H, Ichihara E, Morita A, Makimoto G, Kagawa S, Ishii A Support Care Cancer. 2025; 33(4):283.

PMID: 40088298 DOI: 10.1007/s00520-025-09318-8.

Chemotherapy-Induced Alopecia in Ovarian Cancer: Incidence, Mechanisms, and Impact Across Treatment Regimens.

Gaumond S, Beraja G, Kamholtz I, Ferrari L, Mahmoud R, Jimenez J Cancers (Basel). 2025; 17(3).

PMID: 39941780 PMC: 11816305. DOI: 10.3390/cancers17030411.

Chemotherapy induced alopecia in breast cancer patients: A monocentric prospective study.

Ben Kridis W, Boudawara O, Khanfir A Breast Dis. 2024; 43(1):251-255.

PMID: 39213044 PMC: 11380241. DOI: 10.3233/BD-240019.

The Efficacy of Paxman Scalp Cooling System in Preventing Hair Loss in Breast Cancer Patients Receiving Chemotherapy in Western India - Multi-centre Retrospective Cohort Study.

Mekha M, Joshi A, Maniar V, Maheshwari U, Joshi K, Kalaskar P Indian J Dermatol. 2024; 69(1):16-23.

PMID: 38572038 PMC: 10986862. DOI: 10.4103/ijd.ijd_345_23.

Cinnamic acid promotes elongation of hair peg-like sprouting in hair follicle organoids via oxytocin receptor activation.

Kageyama T, Seo J, Yan L, Fukuda J Sci Rep. 2024; 14(1):4709.

PMID: 38409197 PMC: 10897452. DOI: 10.1038/s41598-024-55377-y.

References

Susser W, Grant-Kels J . Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol. 1999; 40(3):367-98; quiz 399-400. DOI: 10.1016/s0190-9622(99)70488-3. View

Williams J, Wood C . A narrative study of chemotherapy-induced alopecia. Oncol Nurs Forum. 2000; 26(9):1463-8. View

Batchelor D . Hair and cancer chemotherapy: consequences and nursing care--a literature study. Eur J Cancer Care (Engl). 2002; 10(3):147-63. DOI: 10.1046/j.1365-2354.2001.00272.x. View

McGarvey E, Baum L, Pinkerton R, Rogers L . Psychological sequelae and alopecia among women with cancer. Cancer Pract. 2002; 9(6):283-9. DOI: 10.1046/j.1523-5394.2001.96007.x. View

Protiere C, Evans K, Camerlo J, Macquart-Moulin G, Viens P, Maraninchi D . Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy. Support Care Cancer. 2002; 10(7):529-37. DOI: 10.1007/s00520-002-0375-y. View

Rosman S . Cancer and stigma: experience of patients with chemotherapy-induced alopecia. Patient Educ Couns. 2004; 52(3):333-9. DOI: 10.1016/S0738-3991(03)00040-5. View

Chiewchanvit S, Noppakun K, Kanchanarattanakorn K . Mucocutaneous complications of chemotherapy in 74 patients from Maharaj Nakorn Chiang Mai Hospital. J Med Assoc Thai. 2004; 87(5):508-14. View

Williamson P, de Berker D . Pohl-Pinkus constrictions of hair following chemotherapy for Hodgkin's disease. Br J Haematol. 2005; 128(5):582. DOI: 10.1111/j.1365-2141.2005.05367.x. View

Frith H, Harcourt D, Fussell A . Anticipating an altered appearance: women undergoing chemotherapy treatment for breast cancer. Eur J Oncol Nurs. 2007; 11(5):385-91. DOI: 10.1016/j.ejon.2007.03.002. View

10.

Yun S, Kim S . Hair loss pattern due to chemotherapy-induced anagen effluvium: a cross-sectional observation. Dermatology. 2007; 215(1):36-40. DOI: 10.1159/000102031. View

11.

Hinds G, Thomas V . Malignancy and cancer treatment-related hair and nail changes. Dermatol Clin. 2007; 26(1):59-68, viii. DOI: 10.1016/j.det.2007.08.003. View

12.

Jimenez J, Roberts S, Mejia J, Mauro L, Munson J, Elgart G . Prevention of chemotherapy-induced alopecia in rodent models. Cell Stress Chaperones. 2008; 13(1):31-8. PMC: 2666212. DOI: 10.1007/s12192-007-0005-1. View

13.

Fan S, Eiser C . Body image of children and adolescents with cancer: A systematic review. Body Image. 2009; 6(4):247-56. DOI: 10.1016/j.bodyim.2009.06.002. View

14.

Trueb R . Chemotherapy-induced hair loss. Skin Therapy Lett. 2010; 15(7):5-7. View

15.

Hagedoorn M, Kreicbergs U, Appel C . Coping with cancer: The perspective of patients' relatives. Acta Oncol. 2011; 50(2):205-11. DOI: 10.3109/0284186X.2010.536165. View

16.

Kiebert G, Hanneke J, de Haes C, Kievit J, van de Velde C . Effect of peri-operative chemotherapy on the quality of life of patients with early breast cancer. Eur J Cancer. 1990; 26(10):1038-42. DOI: 10.1016/0277-5379(90)90046-v. View

17.

Roe H . Chemotherapy-induced alopecia: advice and support for hair loss. Br J Nurs. 2011; 20(10):S4-11. DOI: 10.12968/bjon.2011.20.Sup5.S4. View

18.

Yeager C, Olsen E . Treatment of chemotherapy-induced alopecia. Dermatol Ther. 2011; 24(4):432-42. DOI: 10.1111/j.1529-8019.2011.01430.x. View

19.

Katikaneni R, Ponnapakkam T, Suda H, Miyata S, Sakon J, Matsushita O . Treatment for chemotherapy-induced alopecia in mice using parathyroid hormone agonists and antagonists linked to a collagen binding domain. Int J Cancer. 2011; 131(5):E813-21. PMC: 3693573. DOI: 10.1002/ijc.27379. View

20.

Gude D . Tackling Chemotherapy-induced Alopecia. Int J Trichology. 2012; 4(1):47-8. PMC: 3358943. DOI: 10.4103/0974-7753.96098. View